专题：Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

This cluster of papers focuses on the diagnosis, management, and pathogenesis of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It covers evidence-based guidelines, cellular and molecular mechanisms of fibrosis, therapeutic translation, treatment trials with drugs like pirfenidone and nintedanib, as well as the role of myofibroblasts and epithelial-mesenchymal transition in lung fibrosis.
最新文献
AI-driven toolset for IPF and aging research associates lung fibrosis with accelerated aging

article Full Text OpenAlex

Methotrexate-Associated Hypersensitivity Pneumonitis After 15 Years of Use: A Case Report and Literature Review

article Full Text OpenAlex

Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury

letter Full Text OpenAlex

Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis

review Full Text OpenAlex

S. aureus upregulation of MUC13 modulates mucosal remodeling in chronic rhinosinusitis via MEK1/2 and WNT2B

article Full Text OpenAlex

Pulmonary sarcoidosis

reference-entry Full Text OpenAlex

Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis

article Full Text OpenAlex

A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases

article Full Text OpenAlex

Fibroblast activation and heterogeneity in fibrotic disease

review Full Text OpenAlex

Predictive Biomarkers and Novel Treatments for the Progressive Fibrosing Phenotype in Interstitial Lung Disease Associated with Connective Tissue Disease

review Full Text OpenAlex

近5年高被引文献
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

article Full Text OpenAlex 1861 FWCI349.382

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

article Full Text OpenAlex 1015 FWCI146.845

Fibroblasts: Origins, definitions, and functions in health and disease

review Full Text OpenAlex 789 FWCI26.836

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

article Full Text OpenAlex 573 FWCI107.356

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

review Full Text OpenAlex 523 FWCI16.064

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

article Full Text OpenAlex 469 FWCI66.581

ERS clinical practice guidelines on treatment of sarcoidosis

article Full Text OpenAlex 442 FWCI52.703

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

article Full Text OpenAlex 427 FWCI60.574

Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

article Full Text OpenAlex 411 FWCI125.708

Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment

article Full Text OpenAlex 404 FWCI64.078